PubMed

Type 2 diabetes and intravenous thrombolysis outcome in the setting of ST elevation myocardial infarction.

Zairis MN, Lyras AG, Makrygiannis SS, Psarogianni PK, Adamopoulou EN, Handanis SM, Papantonakos A, Argyrakis SK, Prekates AA, Foussas SG.

Diabetes Care. 2004 Apr;27(4):967-71.PMID: 15047657 [PubMed - indexed for MEDLINE]Related articlesFree article

The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction.

Foussas SG, Zairis MN, Makrygiannis SS, Manousakis SJ, Anastassiadis FA, Apostolatos CS, Patsourakos NG, Glyptis MP, Papadopoulos JK, Xenos DC, Adamopoulou EN, Olympios CD, Argyrakis SK.

Heart. 2007 Aug;93(8):952-6. Epub 2007 Mar 7.PMID: 17344331 [PubMed - indexed for MEDLINE]Related articles

Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).

Madsen MM, Busk M, Søndergaard HM, Bøttcher M, Mortensen LS, Andersen HR, Nielsen TT; DANAMI-2 Investigators.

Am J Cardiol. 2005 Dec 1;96(11):1469-75. Epub 2005 Oct 11.PMID: 16310424 [PubMed - indexed for MEDLINE]Related articles

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

Mak KH, Moliterno DJ, Granger CB, Miller DP, White HD, Wilcox RG, Califf RM, Topol EJ.

J Am Coll Cardiol. 1997 Jul;30(1):171-9.PMID: 9207639 [PubMed - indexed for MEDLINE]Related articles

Extent of ST-segment deviation in the single ECG lead of maximum deviation present 90 or 180 minutes after start of thrombolytic therapy best predicts outcome in acute myocardial infarction.

Schröder K, Wegscheider K, Zeymer U, Neuhaus KL, Schröder R.

Z Kardiol. 2001 Aug;90(8):557-67.PMID: 11565211 [PubMed - indexed for MEDLINE]Related articles

Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study.

Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG.

J Am Coll Cardiol. 1993 Dec;22(7):1788-94.PMID: 8245329 [PubMed - indexed for MEDLINE]Related articles

Primary coronary angioplasty in patients with ST segment elevation acute myocardial infarction and diabetes.

Dudek D, Mielecki W, Wizimirski M, Rakowski T, Dziewierz A, Sorysz D, Tomala M, Zorkun C, Zmudka K, Dubiel JS.

Kardiol Pol. 2004 Sep;61(9):232-41; discussion 242. English, Polish. PMID: 15531935 [PubMed - indexed for MEDLINE]Related articlesFree article

B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.

Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, Gibson CM, Antman EM, Braunwald E.

J Am Coll Cardiol. 2004 Jul 21;44(2):335-9.PMID: 15261928 [PubMed - indexed for MEDLINE]Related articles

Degree of activity at the onset of myocardial infarction and thrombolysis outcome.

Zairis MN, Psaltiras GP, Papadaki OA, Psarogianni PK, Lyras AG, Giannakopoulos AK, Andrikopoulos GK, Adamopoulou EN, Olympios CD, Foussas SG.

Int J Cardiol. 2003 Nov;92(1):35-41.PMID: 14602214 [PubMed - indexed for MEDLINE]Related articles

Thrombolysis followed by early revascularization: an effective reperfusion strategy in real world patients with ST-elevation myocardial infarction.

Jaffe R, Halon DA, Karkabi B, Goldstein J, Rubinshtein R, Flugelman MY, Lewis BS.

Cardiology. 2007;107(4):329-36. Epub 2007 Jan 24.PMID: 17268198 [PubMed - indexed for MEDLINE]Related articles

Thrombolytic failure with streptokinase in acute myocardial infarction using electrocardiogram criteria.

Lee YY, Tee MH, Zurkurnai Y, Than W, Sapawi M, Suhairi I.

Singapore Med J. 2008 Apr;49(4):304-10.PMID: 18418522 [PubMed - indexed for MEDLINE]Related articlesFree article

Continuous 12-lead electrocardiographic ST monitoring adds prognostic information to the thrombolysis in myocardial infarction risk score in patients with non-ST-elevation acute coronary syndromes.

Zairis MN, Lyras AG, Makrygiannis SS, Beldekos DJ, Mainas KA, Patsourakos NG, Ampartzidou OS, Adamopoulou EN, Prekates AA, Argyrakis SK, Foussas SG.

Clin Cardiol. 2005 Apr;28(4):189-92.PMID: 15869053 [PubMed - indexed for MEDLINE]Related articles

Half-dose thrombolysis to begin with, when immediate coronary angioplasty in acute myocardial infarction is not possible.

La Scala E, Steffenino G, Dellavalle A, Baralis G, Meinardi F, Margaria F, Goletto S, Rolfo F.

Ital Heart J. 2004 Sep;5(9):678-83.PMID: 15568596 [PubMed - indexed for MEDLINE]Related articles

Diabetes mellitus is a strong negative prognostic factor in patients with myocardial infarction treated with thrombolytic therapy.

Strandberg LE, Ericsson CG, O'Konor ML, Bergstrand L, Lundin P, Rehnqvist N, Tornvall P.

J Intern Med. 2000 Aug;248(2):119-25.PMID: 10947890 [PubMed - indexed for MEDLINE]Related articles

Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.

Timmer JR, Ottervanger JP, de Boer MJ, Boersma E, Grines CL, Westerhout CM, Simes RJ, Granger CB, Zijlstra F; Primary Coronary Angioplasty vs Thrombolysis-2 Trialists Collaborators Group.

Arch Intern Med. 2007 Jul 9;167(13):1353-9.PMID: 17620527 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.

Sosnowski C, Janeczko-Sosnowska E, Woźniak J, Jasiński B, Dabrowski R, Sumiński A, Wiernikowski A, Ostrzycki A, Szwed H, Ruzyłło W.

Kardiol Pol. 2007 Oct;65(10):1181-6; discussion 1187-9. English, Polish. PMID: 17979046 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term, cause-specific mortality after myocardial infarction in diabetes.

Timmer JR, Ottervanger JP, Thomas K, Hoorntje JC, de Boer MJ, Suryapranata H, Zijlstra F; Zwolle Myocardial Infarction Study Group.

Eur Heart J. 2004 Jun;25(11):926-31.PMID: 15172464 [PubMed - indexed for MEDLINE]Related articlesFree article

Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.

Foussas SG, Zairis MN, Lyras AG, Patsourakos NG, Tsirimpis VG, Katsaros K, Beldekos DJ, Handanis SM, Mytas DZ, Karidis KS, Tselioti PG, Prekates AA, Ambrose JA.

Am J Cardiol. 2005 Aug 15;96(4):533-7.PMID: 16098307 [PubMed - indexed for MEDLINE]Related articles

Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.

Dobrzycki S, Mezyński G, Kralisz P, Prokopczuk P, Nowak K, Kochman W, Zuk J, Bachórzewska-Gajewska H, Sawicki Z, Poniatowski B, Korecki J, Musiał WJ.

Kardiol Pol. 2006 Aug;64(8):793-9; discussion 800-1.PMID: 16981054 [PubMed - indexed for MEDLINE]Related articlesFree article

Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial.

Di Mario C, Dudek D, Piscione F, Mielecki W, Savonitto S, Murena E, Dimopoulos K, Manari A, Gaspardone A, Ochala A, Zmudka K, Bolognese L, Steg PG, Flather M; CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators.

Lancet. 2008 Feb 16;371(9612):559-68.PMID: 18280326 [PubMed - indexed for MEDLINE]Related articles